Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation.

Front Oncol · 2023 · PMC10477982 · PMID 37675232

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

Accordingly, the comparison showed a better PFS of AITL in CHOP than ICED with a marginal significance ( Figure 4B ).

also in 5,069 other papers

showed a trendno p-value reported

On the other hand, ICED showed a trend toward better PFS in PTCL-NOS patients, although it was not statistically significant ( Figure 4C ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.